Safety and Glycemic Outcomes During the MiniMed™ Advanced Hybrid Closed-Loop System Pivotal Trial in Adolescents and Adults with Type 1 Diabetes
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Safety and Glycemic Outcomes During the MiniMed™ Advanced Hybrid Closed-Loop System Pivotal Trial in Adolescents and Adults with Type 1 Diabetes
Authors
Keywords
-
Journal
Diabetes Technology & Therapeutics
Volume -, Issue -, Pages -
Publisher
Mary Ann Liebert Inc
Online
2021-10-26
DOI
10.1089/dia.2021.0319
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A comparison of two hybrid closed-loop systems in adolescents and young adults with type 1 diabetes (FLAIR): a multicentre, randomised, crossover trial
- (2021) Richard M Bergenstal et al. LANCET
- New glycemic metrics and traditional clinical and laboratory profiles of children and adolescents with type 1 diabetes mellitus in an outpatient follow-up
- (2021) Ricardo Rodrigues et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Real‐world performance of the MiniMed ™ 670G system in Europe
- (2021) Julien Da Silva et al. DIABETES OBESITY & METABOLISM
- Rapid Improvement in Time in Range After the Implementation of an Advanced Hybrid Closed-Loop System in Adolescents and Adults with Type 1 Diabetes
- (2021) Pilar Isabel Beato-Víbora et al. Diabetes Technology & Therapeutics
- Multicenter Trial of a Tubeless, On-Body Automated Insulin Delivery System With Customizable Glycemic Targets in Pediatric and Adult Participants With Type 1 Diabetes
- (2021) Sue A. Brown et al. DIABETES CARE
- American Association of Clinical Endocrinology Clinical Practice Guideline: The Use of Advanced Technology in the Management of Persons With Diabetes Mellitus
- (2021) George Grunberger et al. Endocrine Practice
- Real-World Patient-Reported Outcomes and Glycemic Results with Initiation of Control-IQ Technology
- (2020) Jordan E. Pinsker et al. Diabetes Technology & Therapeutics
- Feasibility Study of a Hybrid Closed-Loop System with Automated Insulin Correction Boluses
- (2020) Revital Nimri et al. Diabetes Technology & Therapeutics
- Glucose Control Using a Standard Versus an Enhanced Hybrid Closed Loop System: A Randomized Crossover Study
- (2019) Barbora Paldus et al. Diabetes Technology & Therapeutics
- State of Type 1 Diabetes Management and Outcomes from the T1D Exchange in 2016–2018
- (2019) Nicole C. Foster et al. Diabetes Technology & Therapeutics
- REAL-WORLD IMPLICATIONS OF HYBRID CLOSE LOOP (HCL) INSULIN DELIVERY SYSTEM
- (2019) Eileen R. Faulds et al. Endocrine Practice
- Successful At-Home Use of the Tandem Control-IQ Artificial Pancreas System in Young Children During a Randomized Controlled Trial
- (2019) Gregory P. Forlenza et al. Diabetes Technology & Therapeutics
- Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range
- (2019) Tadej Battelino et al. DIABETES CARE
- Glucose Control in Adults with Type 1 Diabetes Using a Medtronic Prototype Enhanced-Hybrid Closed-Loop System: A Feasibility Study
- (2019) Melissa H. Lee et al. Diabetes Technology & Therapeutics
- One Year Clinical Experience of the First Commercial Hybrid Closed-Loop
- (2019) Rayhan A. Lal et al. DIABETES CARE
- Time in range is associated with carotid intima-media thickness in type 2 diabetes
- (2019) Jingyi Lu et al. Diabetes Technology & Therapeutics
- Safety and Performance of the Omnipod Hybrid Closed-Loop System in Adults, Adolescents, and Children with Type 1 Diabetes Over 5 Days Under Free-Living Conditions
- (2019) Jennifer L. Sherr et al. Diabetes Technology & Therapeutics
- Six-Month Randomized, Multicenter Trial of Closed-Loop Control in Type 1 Diabetes
- (2019) Sue A. Brown et al. NEW ENGLAND JOURNAL OF MEDICINE
- Increased proportion of time in hybrid closed‐loop “Auto Mode” is associated with improved glycaemic control for adolescent and young patients with adult type 1 diabetes using the MiniMed 670G insulin pump
- (2019) Sara H. Duffus et al. DIABETES OBESITY & METABOLISM
- Long‐term real‐life glycaemic outcomes with a hybrid closed‐loop system compared with sensor‐augmented pump therapy in patients with type 1 diabetes
- (2019) Halis Kaan Akturk et al. DIABETES OBESITY & METABOLISM
- Prospective analysis of the impact of commercialised hybrid closed-loop system on glycaemic control, glycaemic variability and patient-related outcomes in children and adults: a focus on superiority over predictive low glucose suspend technology.
- (2019) Pilar Isabel Beato-Víbora et al. Diabetes Technology & Therapeutics
- Six months of hybrid closed loop in the real‐world: An evaluation of children and young adults using the 670G system
- (2019) Cari Berget et al. PEDIATRIC DIABETES
- Real world hybrid closed‐loop discontinuation: Predictors and perceptions of youth discontinuing the 670G system in the first 6 months
- (2019) Laurel H. Messer et al. PEDIATRIC DIABETES
- Association of Time in Range, as Assessed by Continuous Glucose Monitoring, With Diabetic Retinopathy in Type 2 Diabetes
- (2018) Jingyi Lu et al. DIABETES CARE
- Retrospective Analysis of 3-Month Real-World Glucose Data After the MiniMed 670G System Commercial Launch
- (2018) Michael P. Stone et al. Diabetes Technology & Therapeutics
- Performance of Medtronic Hybrid Closed-Loop Iterations, Results from a Randomized Trial in Adolescents with Type 1 Diabetes
- (2018) Martin de Bock et al. Diabetes Technology & Therapeutics
- Safety Evaluation of the MiniMed 670G System in Children 7–13 Years of Age with Type 1 Diabetes
- (2018) Gregory P. Forlenza et al. Diabetes Technology & Therapeutics
- The Relationship of Hemoglobin A1C to Time-in-Range in Patients with Diabetes
- (2018) Robert A. Vigersky et al. Diabetes Technology & Therapeutics
- Day-and-Night Hybrid Closed-Loop Insulin Delivery in Adolescents With Type 1 Diabetes: A Free-Living, Randomized Clinical Trial
- (2016) Martin Tauschmann et al. DIABETES CARE
- Toward Defining the Threshold Between Low and High Glucose Variability in Diabetes
- (2016) Louis Monnier et al. DIABETES CARE
- Glycemia, Treatment Satisfaction, Cognition, and Sleep Quality in Adults and Adolescents with Type 1 Diabetes When Using a Closed-Loop System Overnight Versus Sensor-Augmented Pump with Low-Glucose Suspend Function: A Randomized Crossover Study
- (2016) Amin Sharifi et al. Diabetes Technology & Therapeutics
- Automated Overnight Closed-Loop Control Using a Proportional-Integral-Derivative Algorithm with Insulin Feedback in Children and Adolescents with Type 1 Diabetes at Diabetes Camp
- (2016) Trang T. Ly et al. Diabetes Technology & Therapeutics
- Safety of a Hybrid Closed-Loop Insulin Delivery System in Patients With Type 1 Diabetes
- (2016) Richard M. Bergenstal et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Current State of Type 1 Diabetes Treatment in the U.S.: Updated Data From the T1D Exchange Clinic Registry
- (2015) Kellee M. Miller et al. DIABETES CARE
- Night glucose control with MD-Logic artificial pancreas in home setting: a single blind, randomized crossover trial-interim analysis
- (2013) Revital Nimri et al. PEDIATRIC DIABETES
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started